Business Description
Adynxx Inc
NAICS : 325412
SIC : 2899
ISIN : US00784D1037
Description
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1170.29 | |||||
OCF Margin % | -1170.29 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADYX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adynxx Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.589 | ||
| EPS (TTM) ($) | -4.03 | ||
| Beta | 124.9577 | ||
| 3-Year Sharpe Ratio | -59.39 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0002 | ||
| Shares Outstanding (Mil) | 5.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adynxx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adynxx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.166667:1 Stock Split | 2019-05-06 | 16.12 (+9.66%) | ||
| 0.1:1 Stock Split | 2017-10-06 | 20.11 (-3.12%) | ||
| 0.022857:1 Stock Split | 2013-11-19 | 207.38 (-11.04%) | ||
| 4:1 Stock Split | 2001-08-01 | 196.88 (+0.00%) |
Show
Entries
Adynxx Inc Frequently Asked Questions
What is Adynxx Inc(ADYX)'s stock price today?
The current price of ADYX is $0.00. The 52 week high of ADYX is $0.00 and 52 week low is $0.00.
When is next earnings date of Adynxx Inc(ADYX)?
The next earnings date of Adynxx Inc(ADYX) is .
Does Adynxx Inc(ADYX) pay dividends? If so, how much?
Adynxx Inc(ADYX) does not pay dividend.
Guru Commentaries on OTCPK:ADYX
No articles.
Press Release
Articles on Adynxx Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers